Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Atrial fibrillation (AF) is the most common cardiac arrhythmia. This analysis aimed to determine the sex-gender differences in patients with AF enrolled in the observational AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study. The study was conducted in 360 centers in Italy. During a 4-week...

Full description

Bibliographic Details
Main Authors: Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators
Format: Article
Language:English
Published: PAGEPress Publications 2016-02-01
Series:Italian Journal of Medicine
Subjects:
Atrial fibrillation
sex-gender
oral anticoagulants
CHA2DS2-VASc score.
Online Access:http://www.italjmed.org/index.php/ijm/article/view/649

Similar Items

Similar Items